bariatric surgery and glp 1 vs. GLP-1 Medications: What the Latest Research Shows Choosing Between Weight Loss Medications

Key Findings: - Increased risk of going over recommended weight gain limits - Higher chances of preterm birth (from 13% to 17%) - Rising cases of gestational diabetes (15% to 20%) - Nearly half faced high blood pressure issues While baby sizes and C-section rates remained similar, the impact on maternal health is significant

A recent study found that GLP-1 medications like Ozempic and Wegovy may help improve breast cancer survival rates among women with obesity and type 2 diabetes.

Grocery list included.

Results Twenty-eight RCTs were ultimately included for analysis, involving a total of 77,485 participants

Highlighting reduced polypharmacy and improved outcomes strengthens value propositions with providers and payers

Get insights on coverage, eligibility, and how to access these benefits effectively.